🏛️ Verified NIH Record • Updated 2026-04-23
CB1R in Synthetic Psychoactive Cannabinoids (NCT03539575)
CB1R Availability in Synthetic Psychoactive Cannabinoid Users
🔵 Active, Not Recruiting Observational / Diagnostic 📋 Clinical Research Protocol Sponsor: Yale University
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this research study is to determine whether the CB1R availability is lower in synthetic psychoactive cannabinoid subjects using the most widely available synthetic psychoactive cannabinoids at the time the study is initiated.
Who can join: Review the eligibility criteria below.
Location: Connecticut Mental Health Center — New Haven, Connecticut
Age range: 18 Years to 55 Years
🧪 Interventions in This Study
- [11-C]OMAR (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Connecticut Mental Health Center — New Haven, Connecticut
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Drug Dependence clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.